Skip to main content
. 2024 May 6;30(6):1645–1654. doi: 10.1038/s41591-024-02934-7

Fig. 1. Patient disposition and samples for genomic analysis.

Fig. 1

a, Patient disposition. b, Samples for genomic analysis. The primary reason for treatment discontinuation is shown for each patient. *FoundationOne, FMI. The four patients originally misassigned to cohort C based on local test uncertainty were analyzed here with the relevant set of gene alterations in cohorts A and B. EOT, end of treatment; FMI, Foundation Medicine, Inc.